ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

carboxymethylcellulose

Also written as “Carboxymethylcellulose and Glycerin based artificial tear”, “Optive” and “Carboxymethylcellulose sodium 0.5%, Glycerin 1.0%, Polysorbate 80 0.5%”.

Its studies are mostly in Dry Eye Syndromes · Keratoconjunctivitis Sicca, led by 3 companies.

Drug pageCarboxymethylcellulose: every studyAll 16 studies of it, academic ones too, with its approvals, label and forms.
Furthest: phase 4, since Jul 10, 200910 company-led studies, 1 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
AbbVie70 open or runningphase 4since Jul 10, 2009Oct 21, 2005none ahead
Innovative Medicalits history only20 open or runningphase 4since Nov 9, 2006Nov 9, 2006none ahead
Andover Research Eye Instituteits history only11 open or runningphase 4since Jun 24, 2026Jun 24, 2026none ahead

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of AbbVie only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Oct 21, 2005First study: phase 3 study in Dry Eye SyndromesFirst studyNCT00243711 · 286 enrolled · United States
  2. Aug 8, 2007No phase study in Dry Eye SyndromesNCT00514852 · 316 enrolled · United States
  3. Oct 12, 2007No phase study in Dry Eye SyndromesNCT00544713 · 228 enrolled · United States
  4. Jul 10, 2009Phase 4 study in Dry Eye SyndromesNCT00938704 · 71 enrolled · Germany
  5. Sep 29, 2009Phase 4 study in Dry Eye SyndromesNCT00987727 · 82 enrolled · France
  6. Jan 6, 2014Phase 4 study in Dry Eye SyndromesNCT02028754 · 180 enrolled · China
  7. Apr 16, 2014Phase 4 study in Dry Eye SyndromesNCT02117687 · 80 enrolled · France, United Kingdom

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 7 AbbVie leads, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT02117687Dry Eye Syndromes · France, United Kingdom4CompletedJan 27, 201580
NCT02028754Dry Eye Syndromes · China4CompletedMay 2013180
NCT00987727Dry Eye Syndromes · France4CompletedJul 201082
NCT00938704Dry Eye Syndromes · Germany4CompletedJun 200971
NCT00544713Dry Eye Syndromes · United States–CompletedJun 2008228
NCT00514852Dry Eye Syndromes · United States–CompletedJan 2008316
NCT00243711Dry Eye Syndromes · United States3CompletedApr 2006286

How it is read

Names in the registry

  • “Carboxymethylcellulose and Glycerin based artificial tear”, 2 entries
  • “Optive”, 2 entries
  • “Carboxymethylcellulose sodium 0.5%, Glycerin 1.0%, Polysorbate 80 0.5%”, 1 entry
  • “carboxymethylcellulose 0.5%/glycerin 0.9%”, 1 entry
  • “Sodium Carboxymethylcellulose”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.